Reconsider the Indication of Implantable Cardioverter Defibrillator in Patients With Cardiac Amyloidosis

^*この論文の責任著者

研究成果: ジャーナルへの寄稿 › Letter › 査読

本文言語	英語
ページ（範囲）	546-547
ページ数	2
ジャーナル	Journal of Cardiovascular Electrophysiology
巻	36
号	2
DOI	https://doi.org/10.1111/jce.16521
出版ステータス	出版済み - 2025/02

ASJC Scopus 主題領域

@article{999f697ed78b4bf6b01b458df095552e,

title = "Reconsider the Indication of Implantable Cardioverter Defibrillator in Patients With Cardiac Amyloidosis",

author = "Naoya Kataoka and Teruhiko Imamura",

year = "2025",

month = feb,

doi = "10.1111/jce.16521",

language = "英語",

volume = "36",

pages = "546--547",

journal = "Journal of Cardiovascular Electrophysiology",

issn = "1045-3873",

publisher = "John Wiley and Sons Inc.",

number = "2",

}

TY - JOUR

T1 - Reconsider the Indication of Implantable Cardioverter Defibrillator in Patients With Cardiac Amyloidosis

AU - Kataoka, Naoya

AU - Imamura, Teruhiko

PY - 2025/2

Y1 - 2025/2

UR - http://www.scopus.com/inward/record.url?scp=85211171921&partnerID=8YFLogxK

U2 - 10.1111/jce.16521

DO - 10.1111/jce.16521

M3 - Letter

C2 - 39632406

AN - SCOPUS:85211171921

SN - 1045-3873

VL - 36

SP - 546

EP - 547

JO - Journal of Cardiovascular Electrophysiology

JF - Journal of Cardiovascular Electrophysiology

IS - 2

ER -